190 related articles for article (PubMed ID: 33521319)
1. COVID-19 vaccine: Call for employees in international transportation industries and international travelers as the first priority in global distribution.
Yu Z; Wang G; Goldman E; Zangerl B; Xie N; Cao Y; Chen J; Day SW; Howard SC; Maida M; Ray K; Jablonski MM; Ji J; Postlethwaite A; Gu W; Sun D; Aleya L
Open Med (Wars); 2021; 16(1):134-138. PubMed ID: 33521319
[TBL] [Abstract][Full Text] [Related]
2. The Race for Global Equitable Access to COVID-19 Vaccines.
Md Khairi LNH; Fahrni ML; Lazzarino AI
Vaccines (Basel); 2022 Aug; 10(8):. PubMed ID: 36016194
[TBL] [Abstract][Full Text] [Related]
3. Global COVID-19 Vaccine Inequity: Failures in the First Year of Distribution and Potential Solutions for the Future.
Pilkington V; Keestra SM; Hill A
Front Public Health; 2022; 10():821117. PubMed ID: 35321196
[TBL] [Abstract][Full Text] [Related]
4. Allocating a COVID-19 Vaccine: Balancing National and International Responsibilities.
Lie RK; Miller FG
Milbank Q; 2021 Jun; 99(2):450-466. PubMed ID: 33295679
[TBL] [Abstract][Full Text] [Related]
5. Allergic reactions to Japanese encephalitis vaccine.
Plesner AM
Immunol Allergy Clin North Am; 2003 Nov; 23(4):665-97. PubMed ID: 14753386
[TBL] [Abstract][Full Text] [Related]
6. Determinants of access to the SARS-CoV-2 vaccine: a preliminary approach.
de Oliveira BRB; da Penha Sobral AIG; Marinho MLM; Sobral MFF; de Souza Melo A; Duarte GB
Int J Equity Health; 2021 Aug; 20(1):183. PubMed ID: 34391416
[TBL] [Abstract][Full Text] [Related]
7. Global access to COVID-19 vaccines: a scoping review of factors that may influence equitable access for low and middle-income countries.
Peacocke EF; Heupink LF; Frønsdal K; Dahl EH; Chola L
BMJ Open; 2021 Sep; 11(9):e049505. PubMed ID: 34593496
[TBL] [Abstract][Full Text] [Related]
8. Return to normal pre-COVID-19 life is delayed by inequitable vaccine allocation and SARS-CoV-2 variants.
Liu F; Zhao Z; Ma C; Nie X; Wu A; Li X
Epidemiol Infect; 2022 Jan; 150():e46. PubMed ID: 35067231
[TBL] [Abstract][Full Text] [Related]
9. COVID-19 Global Humanitarian Response Plan: An optimal distribution model for high-priority countries.
Hezam IM
ISA Trans; 2022 May; 124():1-20. PubMed ID: 33867131
[TBL] [Abstract][Full Text] [Related]
10. Supply chains create global benefits from improved vaccine accessibility.
Wang D; Bjørnstad ON; Lei T; Sun Y; Huo J; Hao Q; Zeng Z; Zhu S; Hallegatte S; Li R; Guan D; Stenseth NC
Nat Commun; 2023 Mar; 14(1):1569. PubMed ID: 36944651
[TBL] [Abstract][Full Text] [Related]
11. SARS-COV-2 Vaccines: What Indicators are Associated with the Worldwide Distribution of the First Doses.
Sobral MFF; Bezerra de Oliveira BR; Gomes da Penha Sobral AI; Monteiro Marinho ML; Duarte GB; de Souza Melo A
Inquiry; 2021; 58():469580211060184. PubMed ID: 34823403
[TBL] [Abstract][Full Text] [Related]
12. The British variant of the new coronavirus-19 (Sars-Cov-2) should not create a vaccine problem.
Conti P; Caraffa A; Gallenga CE; Kritas SK; Frydas I; Younes A; Di Emidio P; Tetè G; Pregliasco F; Ronconi G
J Biol Regul Homeost Agents; 2021; 35(1):1-4. PubMed ID: 33377359
[TBL] [Abstract][Full Text] [Related]
13. Vaccines for a healthy future: 21st DCVMN Annual General Meeting 2020 report.
Pagliusi S; Hayman B; Jarrett S
Vaccine; 2021 Apr; 39(18):2479-2488. PubMed ID: 33838948
[TBL] [Abstract][Full Text] [Related]
14. COVID-19 Vaccine Diplomacy and Equitable Access to Vaccines Amid Ongoing Pandemic.
Sharun K; Dhama K
Arch Med Res; 2021 Oct; 52(7):761-763. PubMed ID: 33941393
[TBL] [Abstract][Full Text] [Related]
15. Global geographic trends in antimicrobial resistance: the role of international travel.
Frost I; Van Boeckel TP; Pires J; Craig J; Laxminarayan R
J Travel Med; 2019 Dec; 26(8):. PubMed ID: 31115466
[TBL] [Abstract][Full Text] [Related]
16. Equitable and Feasible Distribution of SARS-CoV-2 Vaccines for All in Africa.
Rogers AB; Barrie MB; Fallah MP; Kelly JD
Am J Trop Med Hyg; 2021 Jun; 105(2):278-280. PubMed ID: 34181573
[TBL] [Abstract][Full Text] [Related]
17. Redressing COVID-19 vaccine inequity amidst booster doses: charting a bold path for global health solidarity, together.
Rackimuthu S; Narain K; Lal A; Nawaz FA; Mohanan P; Essar MY; Charles Ashworth H
Global Health; 2022 Feb; 18(1):23. PubMed ID: 35193616
[TBL] [Abstract][Full Text] [Related]
18. Temporal Trend of COVID-19 Vaccine Acceptance and Factors Influencing International Travellers.
Onwan M; Matsee W; Lawpoolsri S; Pisutsan P; Siripoon T; Punrin S; Piyaphanee W
Trop Med Infect Dis; 2022 Sep; 7(9):. PubMed ID: 36136634
[TBL] [Abstract][Full Text] [Related]
19. The future of Cochrane Neonatal.
Soll RF; Ovelman C; McGuire W
Early Hum Dev; 2020 Nov; 150():105191. PubMed ID: 33036834
[TBL] [Abstract][Full Text] [Related]
20. Global regulatory reforms to promote equitable vaccine access in the next pandemic.
Mahoney R; Hotez PJ; Bottazzi ME
PLOS Glob Public Health; 2023; 3(10):e0002482. PubMed ID: 37851688
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
